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Abstract: The oxoaporphine alkaloid lysicamine (1), and three proaporphine alkaloids, 
litsericinone (2), 8,9,11,12-tetrahydromecambrine (3) and hexahydromecambrine A (4) 
were isolated from the leaves of Phoebe grandis (Nees) Merr. (Lauraceae). Compounds 2 
and 3 were first time isolated as new naturally occurring compounds from plants. The 
NMR data for the compounds 2–4 have never been reported so far. Compounds 1 and 2 
showed significant cytotoxic activity against a MCF7 (human estrogen receptor (ER+) 
positive breast cancer) cell line with IC50 values of 26 and 60 µg/mL, respectively. 
Furthermore, in vitro cytotoxic activity against HepG2 (human liver cancer) cell line was 
evaluated for compounds 1–4 with IC50 values of 27, 14, 81 and 20 µg/mL, respectively. 
Lysicamine (1) displayed strong antibacterial activity against Bacillus subtilis (B145), 
Staphylococcus aureus (S1434) and Staphylococus epidermidis (a clinically isolated strain) 
with inhibition zones of 15.50 ± 0.57, 13.33 ± 0.57 and 12.00 ± 0.00 mm, respectively. 
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However, none of the tested pathogenic bacteria were susceptible towards compounds 2 
and 3. 
Keywords: Phoebe grandis; Lauraceae; aporphine alkaloid; cytotoxic; antibacterial 
 
1. Introduction  
Cancer is the most common and fatal disease and accounted for 7.6 million deaths (about 13% of all 
deaths) in 2008. Deaths from cancer worldwide are projected to continue to rise to over 11 million in 
2030 [1]. Breast cancer is one of the main life-treatening diseases that a woman may have to face 
during her lifetime and is the most widespread [2]. 
About 60% of anticancer drugs used nowadays are obtained from natural sources [3]. Out of total 
250,000 plant species existing on Earth approximately one thousand have known anticancer potential. 
A large number of plant species have been screened through bioassays in the search for novel  
plant-based anticancer drugs [4]. The present investigation aimed to assess the cytotoxic potential of 
alkaloids isolated from leaves of Phoebe grandis (Nees) Merr. (Lauraceae) on selected cell lines. 
Over the last decade, antibiotics which were considered to be miracle drugs have been losing their 
effectiveness as pathogens evolve resistance against them [5]. Antibacterial resistance continues to grow 
quickly among key pathogens such as Staphylococcus epidermidis (a Gram-positive bacterium)—
which is a part of human skin flora and also can be found in the mucous membranes and in animals [6]; 
Staphylococcus aureus (a Gram-positive bacterium) is frequently found in the human respiratory tract 
and on the skin, and it is estimated that 20% of the human population are long-term carriers of  
S. aureus [7,8]; Bacillus subtilis (a Gram-positive bacterium) is known as the ‘hay bacillus or grass 
bacillus’, commonly found in soil, and more evidence suggests that B. subtilis is a normal gut 
commensal in humans [9]; Pasteurella multocida, a Gram-negative bacterium, causes a range of 
diseases in mammals and birds, including fowl cholera in poultry [10,11] and Enterobacter cloacae,  
a Gram-negative bacterium, is commonly found in infections among burn victims, immunocompromised 
patients, and patients with malignancies [12]. Development of new antibacterial agents is imperative. 
The increased prevalence of antibiotic-resistant bacteria due to the extensive use of antibiotics may 
render the current antimicrobial agents insufficient to control some bacterial diseases. Therefore, the 
search for new promising drugs and especially plant- drug derived may give a solution for the drug 
resistance crisis. 
Several medicinal plants have been extensively studied in order to find more effective and less toxic 
compounds. Lauraceae is one of the major families of plants, which is widespread in the tropical and 
subtropical regions, particularly in tropical America, Africa and Southeast Asia [13]. The Lauraceae or 
laurel family is known as “Medang” or “Tejur” by the Malays, and comprises a group of flowering 
plants included in the order Laurales; it consists of 55 genera and over 2,500 (perhaps as many as 
4,000) species worldwide and about 16 genera and 213 species are found in Malaysia [14,15].  
In Malaysia the species are largely montane. Phoebe species commonly grow most abundantly in 
Borneo and Peninsular Malaysia from central Perak to Malacca. Phoebe species are rich in alkaloidal 
constituents [16–18] and have been reported to contain the rare propaorphine-tryptamine dimers [19,20], 
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aporphines [19,21–25], proaporphine [19,25–27] and oxoaporphines [21,25,27] compounds. An interesting 
aporphine alkaloid named laurolitsine isolated from the stems of P. formosana (Hayata) has been used 
as a starting material to prepare bioactive phenanthrene alkaloids [28]. Some species of Phoebe also 
were reported in China, Indonesia, Indochina, Japan, The Philippines and the Malay Peninsula [15] to 
be useful to treat several diseases thanks to their antidiabetic, antibacterial and antifungal activities [24]. 
Aqueous extract of berries of P. lanceolata is an important remedy and has been used in the traditional 
medicine system in India for wounds and sores, whereas ethanolic extracts of P. lanceolata stem bark 
were evaluated for their antibacterial activity against five bacterial species: Staphylococcus aureus 
(along with ten hospital-derived strains), Staphylococcus mutans, Staphylococcus epidermidis, 
Escherichia coli and Klebsiella pneumoniae with MIC range of 50–100 µg/mL [29]. 
Phoebe grandis is locally known in Malaysia as “medang ketanah or tanah” [30,31]. A 
proaporphine alkaloid which occurs in P. grandis is used as a precursor in the synthesis of aporphines 
and proaporphine-tryptamines alkaloids [25]. These alkaloids are known for their unique pharmacological 
activities, as demonstrated by liriodenine which shows antitumor, antibacterial, and antifungal 
activities [27]. Biological screening on the crude alkaloidal extract of the leaves of Phoebe grandis for 
antiplasmodial activity has shown positive results too: IC50 < 8 µg·mL−1 [32]. Although, most of the 
species of Phoebe are rich in alkaloidal contents, a few species are also reported as alkaloid-free [33]. 
We have launched a chemical investigation on the extract. Further investigation of the leaves has now 
led to the isolation of a known oxoaporphine alkaloid, lysicamine (1), and three proaporphine 
alkaloids, litsericinone (2), 8,9,11,12-tetrahydromecambrine (3) and hexahydro-mecambrine A (4) 
(Figure 1). Compounds 2 and 3 were isolated for the first time as natural compounds. Compound 4 has 
also been isolated from Phoebe scortechinii [34] and was previously synthesized by Nakasato [35]. 
Figure 1. Alkaloids 1–4 isolated from Phoebe grandis (Nees) Merr. (Lauraceae). 
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The objective of this research was to isolate and identify bioactive compounds from  
Phoebe grandis (Nees) Merr. (Lauraceae) with potential cytotoxicity against the MCF7 and HepG2 
cell lines and test their antibacterial activities. 
2. Results and Discussion 
2.1. Compound characterization  
Lysicamine (1) was obtained as a yellow amorphous solid. [α]29 D  = −25 (c = 0.00008, CHCl3). The 
mass spectrum showed the [M+H]+ peak at m/z = 292.0963, which corresponds to a molecular formula 
of C18H13NO3. (calcd. for C18H14NO3, 292.0929). Other significant fragmentations observed were  
at m/z 277, which may be attributed to the loss of a CH3 molecule, [M−15]+. The UV spectrum  
showed absorption maxima at 236, 267, 360 and 396 nm, indicating the existence of a highly 
unsaturated oxoaporphine chromophore [36,37]. The IR spectrum showed a conjugated ketone peak at 
1665 cm−1 [37,38]. The 1H-NMR spectrum showed two distinct methoxyl peaks at δ 4.00 and δ 4.08, 
which were probably situated at C-1 and C-2. H-3 appeared as a singlet at δ 7.21. Two doublets  
(J = 5.2 Hz) typical of the H-4 and H-5 signals of an oxoaporphine were observed at δ 7.78 and δ 8.88, 
respectively. The H-5 proton was deshielded by the neighbouring N atom. A very downfield signal at δ 
9.16 appeared as doublet of doublet with J1 = 8.4 and J2 = 0.7 belongs to H-11. In addition, a doublet 
of doublet peak was observed at δ 8.57 (1H, dd, J1 = 7.9 Hz, J2 = 1.4 Hz; H-8) which experienced a 
deshielding effect from the neighbouring C-7 carbonyl group. The peak appeared as doublet-triplet at  
δ 7.75 with J1 = 8.52 Hz and J2 = 1.64Hz was assigned for H-9 whereas H-10 resonated at δ 7.56 as 
doublet-triplet with J1 = 8.52 Hz and J2 = 1.64 Hz. The 13C-NMR spectrum gave a total of eighteen 
carbons which validated the molecular formula of C18H13NO3. Analysis of the 13C-NMR spectrum 
gave nine quaternary carbons. Hence, compound 1 is an oxoaporphine alkaloid and in fact it was 
identified as lysicamine by the full agreement of the 1H- and 13C-NMR data of 1 with the literature 
values for that compound [39,40]. 
Litsericinone (2) was isolated as a yellow amorphous solid, [α]29 D  = −25 (c = 0.00004, CHCl3). This 
proaporphine alkaloid exhibited an [M+H]+ peak in the LCMS-IT-TOF ESI (positive mode) mass 
spectrum at m/z 286.1421 which correlated to the molecular formula of C17H19NO3 (calcd. for 
C17H20NO3, 286.1432). The UV spectrum revealed three peaks at 300, 236 and 207 nm, which 
indicated the existence of a conjugated system [37]. The IR spectrum revealed a very significant 
carbonyl absorption at 1712.52 cm−1. In addition, the presence of a methylenedioxyl group was proven 
by its characteristic absorption peaks at 1248.37 cm−1 and 934.90 cm−1, which indicate asymmetric  
C-O-C stretching. 
The 1H-NMR spectrum showed one aromatic proton singlet at δ 6.51 which may be ascribed to H-3. 
H-6a resonated at δ 4.26 (dd, J, J’ = 9.8, 6.9Hz). The methylenedioxyl protons appeared as a pair of 
doublets at δ 5.89 and δ 5.86 with J = 1.3 Hz. The aliphatic protons of ring D resonated as multiplets 
between δ 1.91 to 2.68, while H-7 appeared as multiplet at δ 2.73 and δ 1.87 as showed in HSQC 
spectrum. The above observations were reinforced by COSY experiment which showed correlations 
between vicinal protons; H4ax/H5ax, H4eq/H5eq, H5ax/H4ax, H5eq/H4eq, H6a/H7eq, H8eq/H9eq, H9eq/H8eq, 
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H11ax/H12ax and H12ax/H11ax. Interestingly, H6a revealed correlation to H7eq suggesting the 
possibility that H6a is in an equatorial configuration. 
The 13C-NMR spectrum of litsericinone (2) showed the presence of seventeen carbon atoms, 
whereas the DEPT experiment displayed the presence of seven methylenes, a methylenedioxyl and two 
methine signals. The 13C-NMR spectrum revealed the C-10 carbonyl peak at δ 211.12 and the 
quarternary carbon showed five signal peaks between δ 123.91 to 148.90. The characteristic 
proaporphine quarternary C-7a spirocarbon appeared at δ 46.14. The complete assignments of all 
protons and carbons (Table 1) were aided by the HSQC and HMBC experiments. The proximity of 
H6a and H7eq was confirmed by the HMBC correlation peaks between H5eq/C6a and H7eq/C6a. Figure 
2 shows the HMBC and COSY correlation of litsericinone (2). 
Table 1. 13C-NMR (150 MHz), 1H-NMR (600 MHz) and HMBC spectral data of litsericinone, 
(2) in CDCl3 (δ in ppm, J in Hz). 
Position 13C (δ, CDCl3) Type 1H (J, Hz) HMBC (2J, 3J) 
1 148.9 Cq -  
1a 141.1 Cq -  
1b 123.9 Cq -  
2 141.1 Cq -  
3 106.9 CH 6.51 s C1, C1a, C2, C4 
3a 126.7 Cq -  
4 25.1 CH2 
2.87 m (ax) C3, C1b, C1a 
2.75 m (eq) C3, C1b, C1a 
5 43.9 CH2 
3.55 m (ax) C4, C6a, C1b 
3.16 m (eq) C4, C6a 
6a 56.8 CH 
4.26 dd 
C5, C7 (J = 6.9 Hz, 
J = 9.8 Hz) 
7 44.1 CH2 
2.73 m (ax) C3, C3a, C1a 
1.87 m (eq) C12, C7a, C6a 
7a 46.2 Cq - - 
8 38.5 CH2 
2.68 m (ax) C10 
2.41 m (eq) C9, C7a, C10 
9 36.2 CH2 
2.50 m (ax) C8, C7a, C10 
1.91 m (eq) C11, C7a, C10 
10 211.1 C=O - - 
11 38.9 CH2 
2.46 m (ax) C10 
2.45 m (eq) C12, C7a, C10 
12 34.3 CH2 
2.10 m (ax) C9, C7, C7a, C3a, C10 
2.00 m (eq) C9, C7a, C3a, C10 
Methylenedioxy 
(O-CH2-O) 
100.9 CH2 
5.89 d (J = 1.3 Hz) C1,C2  
5.86 d (J = 1.3 Hz) C1,C2 
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Figure 2. Key HMBC (→) and COSY (▬) correlations of litsericinone (2). 
 
8,9,11,12-Tetrahydromecambrine, (3) was isolated as a yellow amorphous solid, [α]29 D  = −25  
(c = 0.00004, CHCl3). The LCMS-IT-TOF mass spectrum of this proaporphine type of alkaloid 
showed a [M+H]+ peak at m/z = 300.1596 which correlated to the molecular formula C18H21NO3 
(calcd. for C18H22NO3, 300.1521). The UV spectrum showed an absorption peak at 203 nm. The IR 
spectrum showed a very significant carbonyl absorption peak at 1712.80 cm−1 due to C=O stretching 
vibrations. The presence of the methylenedioxyl group was proven by its characteristic absorption 
peaks at 1254.45 and 944.84 cm−1, which indicate the asymmetric C-O-C stretching. 
The 1H-NMR spectrum displayed a pair of doublet peaks at δ 5.88 (d, J = 1.2 Hz) and 5.83 (d,  
J = 1.2 Hz) that correspond to the methylenedioxyl group at positions C-1 and C-2. A singlet peak 
appeared at δ 6.49 representing a proton attached to a benzene ring at the C-3 position. There is a 
strong singlet peak at δ 2.39 indicating a N-methyl group. The aliphatic protons appeared between δ 
1.70 to 3.30. These peaks supported were by the COSY experiment that showed correlation peaks 
between H5ax/H4ax, H4ax/H5ax, H6a/H7ax, H7ax/H6a, H6a/H7eq, H7eq/H6a, H11/H12ax, H12ax/H11, 
H11/H12eq and H12eq/H11. The 13C-NMR spectrum of 3 showed the presence of eighteen carbons and 
the DEPT experiment showed the presence of seven methylene carbons (CH2) and one methylenedioxyl 
group. The carbonyl group at C-10 position resonated at δ 211.65 and the N-methyl group at δ 43.47. 
The quaternary carbon at the C-7a position appeared at δ 46.04. The assignments of all carbons were 
established through the aid of the HSQC and HMBC experiments (Table 2). Figure 3 shows the 
HMBC and COSY correlation of the 8, 9, 11, 12-tetrahydromecambrine (3). 
Table 2. 13C-NMR (150 MHz), 1H-NMR (600 MHz) and HMBC spectral data of  
8,9,11,12-tetrahydromecambrine (3) in CDCl3 (δ in ppm, J in Hz). 
Position 13C (δ, CDCl3) Type 1H (J, Hz) HMBC (2J, 3J) 
1 140.7 Cq - - 
1a 134.3 Cq - - 
1b 124.5 Cq - - 
2 148.2 Cq - - 
3 106.5 CH 6.49 s C1a, C1, C2,C4 
3a 126.9 Cq -  
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Table 2. Cont. 
Position 13C (δ, CDCl3) Type 1H (J,Hz) HMBC (2J,3J) 
4 27.4 CH2 2.92 (m) ax C1b, C5 
2.72 (m) eq C1b, C1a, C3 
5 55.0 CH2 3.09 (m) ax C1b, C4, NCH3, C6a 
2.45 (m) eq 
6a 65.7 CH 3.30 br s - 
7 44.5 CH2 2.59 (m) ax C3a, C1a, C8, C7a, C6a 
1.75 (m) eq C8, C12, C7a, C6a 
7a 46.0 Cq - - 
8 34.6 CH2 2.14 (m) ax C3a, C12, C7 
2.02 (m) eq C3a, C12, C7a 
9 39.0 CH2 2.47 (m) C8, C11, C7a 
 C8, C11, C7a 
10 211.7 C=O - - 
11 38.6 CH2 2.70 (m) ax C12, C7a 
2.43 (m) eq C12, C7a 
12 36.5 CH2 2.50 (m) ax C8, C11, C7 
1.93 (m) eq C3a, C8, C11, C7a 
N-CH3 43.5 CH3 2.39 s C5, C6a 
Methlenedioxy 100.6 CH2 5.88 d (J = 1.2) C1, C2 
(O-CH2-O) 5.83 d (J = 1.2) C1, C2 
Figure 3. Key HMBC (→) and COSY (▬) of 8,9,11,12-tetrahydromecambrine (3). 
 
Hexahydromecambrine A (4) was isolated as an amorphous solid, [α]29 D  = +100 (c = 0.00003, 
CHCl3). The mass spectrum showed a molecular ion peak at m/z = 302.9177 [M+H]+, thus suggesting 
a molecular formula of C18H23NO3 (calcd. for C18H24NO3, 302.9167). The UV spectrum showed three 
peaks at 300, 245 and 265 nm, which indicate the existence of a conjugated system [37]. The IR 
spectrum showed a broad absorption band at 3391.78 cm−1, indicating the presence of a hydroxyl 
group. The methylenedioxyl group absorbed at 1254.36 and 929.07 cm−1. There was no carbonyl 
group present in the IR spectrum. 
The 1H-NMR for this alkaloid showed a pair of doublet peaks at δ 5.90 ppm (d, J = 1.20 Hz) and δ 
5.86 ppm (d, J = 1.20 Hz) that correspond to the methylenedioxyl group at positions C-1 and C-2. A 
sharp singlet peak at 6.47 ppm belongs to the H-3 on the benzene ring. The aliphatic protons of ring D 
resonated as multiplets between δ 1.25 to 2.45. H-6a resonated as a multiplet at δ 3.26. A strong peak 
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at δ 2.39 appeared as a sharp peak that was assigned for a N-methyl group. H-10, which is in proximity 
to a hydroxyl group, resonated further upfield at δ 4.00 as a broad multiplet, suggesting the possibility 
of an axial configuration. Interestingly, from the COSY spectra, H-10 was determined at be pseudo-axial 
by the correlations H-10 (δ 4.00) with H-8ax (δ 2.03) and H-11 (δ 1.75). In the case of a pseudo-equatorial 
hydroxyl group, H-10 will resonate at around δ 4.26–4.39 [41]. 
The 13C-NMR spectrum of 4 showed the presence of eighteen carbons, which is in agreement with 
the molecular formula C18H23NO3. The DEPT spectrum showed the presence of one N-methyl, eight 
methylenes, three methines and six quaternary carbons. The methylenedioxyl group resonated at δ 
100.5. The characteristic proaporphine quaternary spirocarbon peak C-7a appeared at δ 46.6. 
Apparently, C-10 resonated at δ 67.1, further strengthening the hypothesis of H-10 being axial. The 
complete assignments of all protons and carbons were aided by the HSQC and HMBC correlation and 
HMBC data were recorded in Table 3. Figure 4 showed HMBC and COSY correlations of 
hexahydromecambrine A. The structure of 4 resembled the structure of 3 except for the fact that the 
carbonyl group in 3 was reduced to a hydroxyl group in 4. 
Table 3. 13C-NMR (150 MHz), 1H-NMR (600 MHz) and HMBC spectral data of 
hexahydromecambrine A (4) in CDCl3 (δ in ppm, J in Hz). 
Position 13C (δ, CDCl3) Type 1H (J, Hz) HMBC (2J, 3J) 
1 148.1 Cq - - 
1a 129.0 Cq - - 
1b 131.0 Cq - - 
2 140.8 Cq - - 
3 105.9 CH 6.46 (s) C1, C2,C4 
3a 124.0 Cq - - 
4 27.3 CH2 2.93 (m) ax C5 
2.71 (m) eq C3a 
5 54.9 CH2 3.11 (m) ax C3a, C6a 
2.46 (m) eq 
6a 65.7 CH 3.26 (m) - 
7 44.3 CH2 2.44 (m) ax C1a 
1.58 (m) eq C12, C9 
7a 46.6 Cq - - 
8 30.2 CH2 2.03 (m) ax C7a, C10 
1.54 (m) eq C12, C7a, C10 
9 31.7 CH2 2.41 (m) ax  
1.46 (m) eq C8, C7a, C10 
10 67.1 CH 4.00 br, m  
11 31.0 CH2 1.75 (m) C12, C7a, C10 
12 29.7 CH2 1.25 (m)  
N-CH3 43.2 CH3 2.39 (s) C5, C6a 
(OCH2O) 100.5 CH2 5.90 (d, J = 1.2) C1, C2 
5.86 (d, J = 1.2) C1, C2 
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Figure 4. Key HMBC (→) and COSY (▬) of hexahydromecambrine A, (4). 
 
2.2. Cell Culture and MTT Cytotoxicity Activity 
A preliminary screening against cancer cells was performed using the MTT method [42] against 
MCF7 and HepG2 cell lines. The cytotoxicity of compounds 1–4 was assayed at various concentrations 
under continuous exposure for 24 h, are expressed in IC50 values (μg/mL), and are summarized in 
Table 4. Doxorubicin was used as a positive control in this study. The results showed compounds 1 
and 2 exhibited cytotoxic activity against both cancer cell lines with IC50 values ranging from  
14–60 μg/mL. Compounds 3 and 4 exhibited cytotoxic activity against the HepG2 cell line with IC50 
values of 81 and 20 μg/mL, respectively. Compounds 3 and 4, however, were not toxic towards the 
MCF7 cell line with IC50 values of more than 100 μg/mL. 
Table 4. The IC50 values of compounds 1–4 and positive control on the MCF7 and HepG2 cell lines. 
Compounds IC50 (µg/mL) at 24 h 
MCF7 HepG2 
1 26 27 
2 60 14 
3 >100 81 
4 >100 20 
Doxorubicin 0.2 1.06 
The results shown in Table 4 implied that the cytotoxic property were related to compounds with  
7-oxo and methylenedioxy functions, which corresponds to the result previously described by 
Likhitwitayawuid et al. [43] that aporphine alkaloids containing a 1,2-methylenedioxy substituent 
appear to play a similar role in the oxoaporphine alkaloids, being required for the expression of 
cytotoxicity of the compounds. The aporphine alkaloid lysicamine (1) demonstrated moderate activity 
comparable to doxorubicin (positive control) against the MCF7 and HepG2 cell lines. It is important to 
notice that compounds 2–4 share the same basic skeleton with different substitution patterns. 
Interestingly, the proaporphine litsericinone (2), showed the highest cytotoxic potency against the 
HepG2 cell line (IC50 = 14 μg/mL) and MCF7 cell line (IC50 = 60 μg/mL) due to the presence of a 
methylenedioxy and a carbonyl group at the C10 position [43,44]. The enhanced cytotoxic activity of 
compound 4 against the HepG2 cell line implies the presence of a 10-hydroxyl in the molecule was 
generally results in better potency than a non-hydroxylated proaporphine. Similarly, the weak 
cytotoxic activity displayed by compound 3 compared to compound 2 may be due to the presence of 
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the N-methyl. These findings also suggested that the aromatic ring system, 7-oxo function, and 
methylenedioxy ring as well as the structural planarity have powerful effects on the cytotoxic activity 
against different cancer cell lines [45]. 
2.3. Antibacterial Activity 
The preliminary screening results of antibacterial activity against five bacterial species are 
summarized in Table 5. Antibacterial activities were indicated by a clear zone of growth inhibition. 
Compounds 13 were evaluated for antibacterial activity using disc diffusion method. A standard 
antibiotic (streptomycin sulfate) was used as a positive control in the assay. Only these three 
compounds were tested only, as the amount of 4 available was insufficient to run the assays. The 
results indicated that lysicamine (1) exhibited a broader spectrum of activity against the microbes 
compared to the other two compounds—litsericinone (2) and 8,9,11,12-tetrahydromecambrine (3), 
which were found to be inactive. 
Table 5. The inhibition zone diameter (in mm) of isolated compounds against selected bacteria. 
Sample 
Inhibition diameter (mm ± SD) 
Staphylococcus 
epidermidis 
Staphylococcus 
aureus 
Bacillus 
subtilis 
Pasteurella 
multocida 
Enterobacter 
cloacae 
(Gram +ve) (Gram +ve) (Gram +ve) (Gram −ve) (Gram −ve) 
1 12.00 ± 0.00 13.33 ± 0.57 15.50 ± 0.57 NI NI 
2 NI NI NI NI NI 
3 NI NI NI NI NI 
4 nt nt nt nt nt 
Streptomycin sulfate a 20.00 ± 0.00 13.66 ± 0.57 21.00 ± 0.00 21.33 ± 1.15 NI 
Note: (NI)—no inhibition observed, (nt)—not tested. Doses of the samples were 1 mg/mL per disc, 
Streptomycin sulfate 10 µg per disc. a—Positive control. 
Lysicamine (1) displayed a strong antibacterial activity against Staphylococcus aureus with 
inhibition zones of 13.33 ± 0.57 mm, which are comparable with those of the positive control 
streptomycin sulfate. Moderate antibacterial activity was observed for compound 1 against 
Staphylococcus epidermidis and Bacillus subtilis, with inhibition zones of 12.00 ± 0.00 mm and  
15.50 ± 0.57 mm, respectively. Pasteurella multocida and Enterobacter cloacae (both Gram-negative 
bacteria) were not susceptible to any of the isolated compounds. Generally, the results showed that 
compound 1 displayed strong activity against Gram-positive bacteria. The negative results obtained 
against the Gram-negative bacteria were not surprising, as in general, these bacteria are more resistant 
than Gram-positive ones [46–48]. These differences may be attributed to the fact that the cell wall in 
Gram-positive bacteria consists of a single layer, whereas the Gram-negative cell wall is a  
multi-layered structure and quite complex [49,50], with an outer membrane consisting of a hydrophilic 
surface rich in lipopolysaccharide molecules [51]. In addition, the periplasmic space contains enzymes 
able to degrade any exogenous molecules and also prevent the entry of inhibitors, including antibiotic 
molecules [47,52]. Gram-positive bacteria do not possess this type of outer membrane and cell wall 
structure. Therefore, antibacterial substances can easily destroy the bacterial cell wall and cytoplasmic 
membrane and produce a leakage of the cytoplasm and its coagulation [53]. The other two compounds 
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2 and 3 were not toxic towards any of the tested pathogenic bacteria since no appreciable zones of 
inhibition were observed. The present results regarding the antibacterial properties of the compounds 
from the leaves of Phoebe grandis (Nees) Merr. indicate that compounds from the plants of this genus 
could be used against the most common Gram-positive pathogen, and that their potential activity is 
probably due to their ability to complex with extracellular and soluble proteins and bacterial cell walls. 
3. Experimental 
3.1. General 
Optical rotations were obtained on a JASCO P-1020 polarimeter. UV spectra were measured using 
Shimadzu UV-1650 PC Ultraviolet-Visible Spectrophotometer. The solvent used was methanol 
(CH3OH) while the wavelength in which the spectrum was recorded is 200–400 nm. IR spectra were 
recorded in CHCl3 on a Perkin Elmer Spectrum 2000-FTIR Spectrometer. NMR spectra were recorded 
in deuterated chloroform (CDCl3) on Bruker AVN instruments (400 and 600 MHz for 1H and 100 and 
150 MHz for 13C, respectively). Chemical shifts reported in ppm on the δ scale and the coupling 
constants are given in Hz. Spectra signals were calibrated using TMS. Mass spectra were obtained 
using a Shimadzu LCMS-IT-TOF instrument. The solvent used was chloroform (CHCl3). Silica gel 
60F, 70–230 mesh ASTM (Merck 7734); silica gel 60F, 230–400 mesh ASTM (Merck 9385); silica 
Gel 60GF254, (Merck 1.07730.1000) were used for chromatographic separations. Thin Layer 
Chromatography analysis was performed by using aluminium supported silica gel 60F254 TLC sheets 
(Merck 1.05554.0001) or glass supported silica gel 60F254 TLC plates (Merck 1.05715.0001). Mayer’s 
and Dragendorff’s reagents were used for alkaloid screening to identify the presence of the alkaloids 
and alkaloid spotting (TLC).  
3.2. Plant Material 
Leaves of Phoebe grandis (Nees) Merr. (Lauraceae) were collected on 19 February 2008 from the 
Bukit Serting Forest Reserve, Negeri Sembilan, Malaysia and the voucher specimen (KL 5540) was 
deposited in the Herbarium of Department of Chemistry, University of Malaya, Kuala Lumpur, 
Malaysia and in the Herbarium of the Forest Research Institute, Kepong, Malaysia. The plant  
(KL 5540) was identified by Mr Teo Leong Eng, a botanist from the Department of Chemistry 
Herbarium, University of Malaya, Kuala Lumpur, Malaysia. 
3.3. Extraction and Isolation of the Alkaloids  
Dried and milled leaves of Phoebe grandis (Nees) Merr. (4.0 kg) were first defatted with hexane  
(7 L) for 3 days at room temperature, then filtered. After that they were moistened with 15% of 
NH4OH, and exhaustively extracted with CH2CI2 using a Soxhlet extractor for about 18 h. The CH2CI2 
extract was reduced to 500 mL followed by acidic extraction using 5% HCI until Mayer’s test was 
negative. The combined extracts were then made alkaline with concentrated ammonia solution to pH 
10–11 and re-extracted with CH2CI2. The CH2Cl2 fractions were washed with distilled H2O and dried 
over anhydrous sodium sulphate. The dichloromethane extract was evaporated to dryness under 
reduced pressure to give the crude extract. 
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The plant residue was extracted with methanol and the methanol was evaporated to dryness and 
then acidified by the addition of 5% hydrochloric acid solution and left to stand overnight. The acid 
solution was then filtered and made alkaline with 10% ammonia solution and reextracted with 
dichloromethane. The dark residue obtained after washing, drying and evaporating to dryness was 
added to the crude alkaloid obtained from the dichloromethane extracts to yield 13.28 g of crude 
alkaloids. This crude alkaloid mixture was subjected to column chromatography over silica gel using 
various ratios of CH2CI2 and MeOH (100:0, 98:2, 97:3, 96:4, 95:5, 94:6, 93:7, 92:8, 91:9, 90:10, 
88:12, 80:20, 70:30, 60:40, 50:50) and finally with pure 100% MeOH. The collected fractions were 
grouped into a series of fractions, monitored with TLC. Each series were then treated separately to 
isolate and purify its alkaloid by extensive column chromatography followed by preparative TLC. 
3.4. Cell Culture and MTT Cytotoxicity Assay  
The MCF-7 and HepG2 cells that were used in this study were obtained from the American Type 
Cell Collection (ATCC). The cells were cultured using RPMI 1640 culturing media (PAA, 
Leverkusen, Germany). Cells were trypsinized and counted using hemocytometer and plated in a 
microtiter plate of 96-wells. After an overnight incubation to allow cell attachment, the medium was 
changed and 0.2 mL of new supplemented medium were added into each well. Cells were then treated 
with the different drug concentrations and incubated at 37 °C, 5% CO2 for 24 h. Each concentration of 
the samples was assayed in triplicate. The colorimetric assay were performed at an absorbance of  
570 nm. Results were expressed as a percentage of control giving a certain percentage of cell viability 
after 24 h exposure to the test agent. The potency of cell growth inhibition for test agent was expressed 
as an IC50 value. 
3.5. Bacterial Cultures and Disc Diffusion Assay 
The in vitro antibacterial activity of the alkaloids was evaluated against five pathogenic 
microorganisms, including three Gram positive bacteria: Staphylococcus epidermidis (a clinically 
isolated strain), Staphylococcus aureus (S1434), Bacillus subtilis (B145) and two Gram negative 
bacteria: Pasteurella multocida (a clinically isolated strain) and Enterobacter cloacae (a clinically 
isolated strain). All the strains were stored in the appropriate medium before use. 
Antibacterial activity of the alkaloids 1–3 was determined by the disc diffusion method [54] with 
slight modifications in terms of sample concentration, volume of sample loaded and use of paper discs. 
The bacteria were cultured at 37 °C for overnight in nutrient broth and potato dextrose broth, 
respectively. The concentrations of the cultures were adjusted turbidometrically at a wavelength of  
600 nm which gave 105–106 colony forming units (CFU) per mL. The compounds to be tested were 
dissolved in dimethyl sulphoxide (DMSO) at concentration of 1 mg/mL. About 10 µL of each sample 
solution was loaded on Whatman No. 1 filter paper disc (Ø6 mm). The disc was placed on the surface 
of the agar plate (nutrient agar or potato dextrose agar) previously inoculated with bacteria. The agar 
plates were then inverted and incubated for 24 h at 37 °C. The antimicrobial activity was recorded by 
measuring the zone of inhibition (IZ) in mm around each disc, against the test organisms. The 
experiments were repeated in triplicate and the results were expressed as average values. The antibiotic 
streptomycin sulfate (10 µg/disc), was used as positive control and DMSO as negative control in the 
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assay. Compound 4 was not evaluated due to the small amount of compound available, not enough for 
antibacterial screening. 
4. Conclusions  
In general, alkaloids from the leaves of Phoebe grandis (Nees) Mer. (Lauraceae) showed a good  
in vitro cytotoxic activity against MCF7 and HepG2 and antibacterial activity against the selected 
bacteria. Lysicamine (1) showed the most promising activity compared to other compounds in the 
study. This study also suggest that the presence of a methylenedioxy group, unsaturated carbonyl 
group, hydrogen bond donor (OH group) and dimethoxy substituent in the compounds contributes to 
the multiple biological activities displayed. Therefore, structure-active relationships (SAR) can further 
investigated to determine the potency of related compound. In a nutshell, this study can be as a basis 
for for selection of plant species for further investigation in drug discovery for potential new natural 
bioactive compounds. 
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